| 000 | 01676 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513035637.0 | ||
| 264 | 0 | _c19951012 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a1071-412X | ||
| 024 | 7 |
_a10.1128/cdli.2.3.281-285.1995 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShearer, W T | |
| 245 | 0 | 0 |
_aTransport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146. _h[electronic resource] |
| 260 |
_bClinical and diagnostic laboratory immunology _cMay 1995 |
||
| 300 |
_a281-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD4 Immunoadhesins _xmetabolism |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfectious Disease Transmission, Vertical |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMaternal-Fetal Exchange |
| 650 | 0 | 4 |
_aPlacenta _xmetabolism |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 700 | 1 | _aDuliege, A M | |
| 700 | 1 | _aKline, M W | |
| 700 | 1 | _aHammill, H | |
| 700 | 1 | _aMinkoff, H | |
| 700 | 1 | _aAmmann, A J | |
| 700 | 1 | _aChen, S | |
| 700 | 1 | _aIzu, A | |
| 700 | 1 | _aMordenti, J | |
| 773 | 0 |
_tClinical and diagnostic laboratory immunology _gvol. 2 _gno. 3 _gp. 281-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/cdli.2.3.281-285.1995 _zAvailable from publisher's website |
| 999 |
_c7663603 _d7663603 |
||